Lower testosterone can lead to a range of health issues, including lower sex drive, impotence, loss of muscle and ...

Here is a roundup of March 2025 U.S. FDA approvals across cancer subtypes, including prostate, bladder and gastrointestinal ...

Corcept's relacorilant hits phase 3 trial success in ovarian cancer, lifting shares 90%. Click here to find out why I rate ...

In an extraordinary display of human compassion, a terminally ill man’s wish for Hokkien mee was granted by a kind stranger who made it his mission to deliver the beloved dish three times. This ...

A major new study from the UK has found that people newly diagnosed with type 2 diabetes (T2D) face a higher risk of ...

In a surprising speech in Paris, Ukrainian President Volodymyr Zelenskyy stated that Russian President Vladimir Putin 'will ...

WARREN, Ohio (MyValleyTributes) – James Wesley Allen, 63, entered eternal life the evening of Friday, March 28, 2025, after a courageous battle against pancreatic cancer. Jim was born on October 15, ...

When your social media account starts spewing out nonsensical or threatening status updates, it's safe to assume that it has ...

The U.S Food & Drug Administration has granted approval for a targeted therapy called CABOMETYX ® to treat pancreatic ...

Pancreatic cancer is on the rise in the United States, but there's another, less common type called pancreatic neuroendocrine ...

MT-601, Marker's lead MAR-T cell therapy, is being evaluated in the nationwide multicenter Phase 1 APOLLO study ( clinicaltrials.gov identifier: NCT05798897) in patients with anti-CD19 CAR-T relapsed ...

Silexion Therapeutics Corp. has announced an expanded development plan for its next-generation siRNA candidate SIL-204. The new dual-route strategy will integrate intratumoral and systemic ...